Results 241 to 250 of about 104,894 (342)
This review explores the role of metabolic reprogramming in inflammatory bowel disease (IBD) by focusing on immune and epithelial cell metabolism, microbial metabolites, and their impact on inflammation. It discusses emerging metabolic therapies and emphasizes the importance of personalized microbiota‐targeted approaches to improve clinical outcomes in
Zemin Tian +6 more
wiley +1 more source
A Rare Diagnosis of HPV-Positive Rectal Squamous Cell Carcinoma in a 59-Year-Old Heterosexual Woman: Implications for Screening Guidelines. [PDF]
Adetiloye AO +4 more
europepmc +1 more source
An Update on the Management of Rectal Neuroendocrine Neoplasms [PDF]
Aviva Frydman, Raj Srirajaskanthan
openalex +1 more source
We assembled National Cancer Center–Clinical Diagnostics Knowledgebase, a clinical genomic knowledgebase of 6935 tumors with matched normal samples, revealing key somatic alterations and actionable variants (70.2% of the cohort). Enrichment of certain different gene mutations was observed between Chinese and American populations, along with a strong ...
Hongrui Li +10 more
wiley +1 more source
Prognostic and predictive value of AXL and C-MET in patients with rectal cancer. [PDF]
Ribas CAPM +9 more
europepmc +1 more source
[Advantages of neoadjuvant therapy in rectal neoplasm].
NANO, Mario +3 more
openaire +2 more sources
Nomogram model performance: The study develops a predictive model using Lasso regression, incorporating key clinical factors, which achieves excellent discriminatory performance in both training and validation sets. Potential for clinical application: The A‐PSAD‐based model shows great promise for personalized PCa screening, particularly in reducing ...
Ziyang Liu +6 more
wiley +1 more source
Rising Incidence of Neuroendocrine Neoplasms in Northern Switzerland-Data From the Cancer Registry. [PDF]
Fischer A +10 more
europepmc +1 more source

